FIELD: medicine.
SUBSTANCE: invention concerns correction high endothelial cythemia at patients with a metabolic syndrome. For this purpose within not less than 4 months carry out the complex therapy including individually picked up hypohigh-calorie diet, rationally dosed out static and dynamic physical loads, and also administration of lisinopril in a dose of 10 mg in the morning, simvastatin in a dose of 20 mg in the evening and tocopherol of an acetate of 50% 0.2 g on 1 capsule 2 times a day. The effect is reached at the expense of normalisation endothelial lepidic tissue of vessels, that, in turn, is caused by normalisation of a reparation of DNA in endotheliocytes.
EFFECT: decrease of risk of a thrombogenesis at patients with metabolic syndrome.
2 ex
